Evidence map›Paper›PMID 31181773›Full record

ReviewCells2019

Viral Appropriation: Laying Claim to Host Nuclear Transport Machinery.

Tanner M Tessier, Mackenzie J Dodge, Martin A Prusinkiewicz, Joe S Mymryk

Abstract readReview
In one paragraph

Review in Cells, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Quantitative comparison of nuclear transport inhibition by SARS coronavirus ORF6 reveals the importance of oligomerization.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  6. Prospective mode of action of Ivermectin: SARS-CoV-2.European journal of medicinal chemistry reports · 2022
    Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Ivermectin: potential candidate for the treatment of Covid 19.The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Tanner M TessierDepartment of Microbiology and Immunology, The University of Western Ontario, London, ON N6A 3K7, Canada. ttessie2@uwo.ca.
Mackenzie J DodgeDepartment of Microbiology and Immunology, The University of Western Ontario, London, ON N6A 3K7, Canada. mdodge@uwo.ca.
Martin A PrusinkiewiczDepartment of Microbiology and Immunology, The University of Western Ontario, London, ON N6A 3K7, Canada. mprusink@uwo.ca.
Joe S MymrykDepartment of Microbiology and Immunology, The University of Western Ontario, London, ON N6A 3K7, Canada. jmymryk@uwo.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Protein nuclear transport is an integral process to many cellular pathways and often plays a critical role during viral infection. To overcome the barrier presented by the nuclear membrane and gain access to the nucleus, virally encoded proteins have evolved ways to appropriate components of the nuclear transport machinery. By binding karyopherins, or the nuclear pore complex, viral proteins influence their own transport as well as the transport of key cellular regulatory proteins. This review covers how viral proteins can interact with different components of the nuclear import machinery and how this influences viral replicative cycles. We also highlight the effects that viral perturbation of nuclear transport has on the infected host and how we can exploit viruses as tools to study novel mechanisms of protein nuclear import. Finally, we discuss the possibility that drugs targeting these transport pathways could be repurposed for treating viral infections.

Indexed as

Active Transport, Cell NucleusHost-Pathogen InteractionsHumansKaryopherinsNuclear PoreProtein TransportVirusesVirus ReplicationKaryopherinsantiviral agentsinfectionnuclear transportprotein localizationviral mimicryvirus

Identifiers

PMID31181773
PMCPMC6627039

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.